Britain's National Health Service (NHS) announced in a release on Tuesday (Apr 2) that in a world's first such initiative, tens of thousands of children and adults living with type 1 diabetes are set to receive an "artificial pancreas".&nbsp;

NHS explained that the "groundbreaking device" is aimed at monitoring a person's blood glucose&nbsp;and it automatically adjusts the amount of insulin given to them through a pump.&nbsp;

The mass rollout by NHS is based on a successful pilot of the technology, in which 835 adults and children were given devices to improve the management of their condition.&nbsp;

The release mentioned that the local NHS systems will begin the identification of those with type 1 diabetes who are eligible for the programme.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/rare-human-case-of-bird-flu-detected-in-texas-the-patients-symptom-was-weirdly-shocking-706726">Rare human case of bird flu detected in Texas. The patient's symptom was weirdly shocking</a>&nbsp;

The health chiefs believe that the identified ones could benefit from the Hybrid Closed Loop system, sometimes called an artificial pancreas, from Tuesday.&nbsp;

As quoted by NHS, Health Minister Andrew Stephenson said, "People living with type 1 diabetes face the constant stress of needing to monitor their blood glucose levels to stay healthy and avoid complications. This new technology will ease the burden on patients and allow them to manage their condition more easily, without needing to draw blood or wear a continuous glucose monitor."&nbsp;

Notably, there are currently 269,095 people living in England with type 1 diabetes.&nbsp;

According to NHS, some people with type 1 diabetes will no longer need to inject themselves with insulin with the availability of this technology. However, they will have to rely on technology to receive this life-saving medication.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/health-and-wellness/alcohol-consumption-linked-to-increased-heart-disease-risk-in-young-women-study-706018">Alcohol consumption linked to increased heart disease risk in young women</a>&nbsp;

Watch:&nbsp;Priti Patel to lead Tories after Sunak?&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/uk-priti-patel-to-lead-tories-after-sunak-707002/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

The healthcare system further noted that the technology will also help prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes.&nbsp;

Dr Clare Hambling, National Clinical Director for diabetes said as quoted by NHS: “This is another example of the NHS leading the way in healthcare, rolling out these groundbreaking devices across England over the next 5 years. This transformative technology holds the power to redefine the lives of those with type 1 diabetes, promising a better quality of life as well as clinical outcomes.”&nbsp;

"Type 1 diabetes is an easily missed diagnosis so if you are concerned about symptoms – the 4Ts – going to the Toilet, passing urine more frequently, with Thirst, feeling Tired and getting Thinner (losing weight), please come forward for support," Hambling added.&nbsp; 
 
“This futuristic technology not only improves medical care but also enhances the quality of life for those affected,” said Professor Partha Kar, NHS national speciality advisor for diabetes.

&nbsp;

(With inputs from agencies)&nbsp;

Britain's National Health Service (NHS) announced in a release on Tuesday (Apr 2) that in a world's first such initiative, tens of thousands of children and adults living with type 1 diabetes are set to receive an "artificial pancreas".

Britain's National Health Service (NHS) announced in a release on Tuesday (Apr 2) that in a world's first such initiative, tens of thousands of children and adults living with type 1 diabetes are set to receive an "artificial pancreas". NHS explained that the "groundbreaking device" is aimed at monitoring a person's blood glucose and it automatically adjusts the amount of insulin given to them through a pump. The mass rollout by NHS is based on a successful pilot of the technology, in which 835 adults and children were given devices to improve the management of their condition. The release mentioned that the local NHS systems will begin the identification of those with type 1 diabetes who are eligible for the programme. Also read: Rare human case of bird flu detected in Texas. The patient's symptom was weirdly shocking The health chiefs believe that the identified ones could benefit from the Hybrid Closed Loop system, sometimes called an artificial pancreas, from Tuesday. As quoted by NHS, Health Minister Andrew Stephenson said, "People living with type 1 diabetes face the constant stress of needing to monitor their blood glucose levels to stay healthy and avoid complications. This new technology will ease the burden on patients and allow them to manage their condition more easily, without needing to draw blood or wear a continuous glucose monitor." Notably, there are currently 269,095 people living in England with type 1 diabetes. According to NHS, some people with type 1 diabetes will no longer need to inject themselves with insulin with the availability of this technology. However, they will have to rely on technology to receive this life-saving medication. Also read: Alcohol consumption linked to increased heart disease risk in young women Watch: Priti Patel to lead Tories after Sunak? × The healthcare system further noted that the technology will also help prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes. Dr Clare Hambling, National Clinical Director for diabetes said as quoted by NHS: “This is another example of the NHS leading the way in healthcare, rolling out these groundbreaking devices across England over the next 5 years. This transformative technology holds the power to redefine the lives of those with type 1 diabetes, promising a better quality of life as well as clinical outcomes.” "Type 1 diabetes is an easily missed diagnosis so if you are concerned about symptoms – the 4Ts – going to the Toilet, passing urine more frequently, with Thirst, feeling Tired and getting Thinner (losing weight), please come forward for support," Hambling added. “This futuristic technology not only improves medical care but also enhances the quality of life for those affected,” said Professor Partha Kar, NHS national speciality advisor for diabetes. (With inputs from agencies)

Tens of thousands in UK with type 1 diabetes to receive artificial pancreas in world’s first initiative

An Israeil firm that claims it has find a cure for diabetes has said it will send a request for initiation of human clinical trials next month in the UK.&nbsp;

Betalin Therapeutics says it has created micro pancreas that will free diabetics from the need of insulin injections and blood sugar monitoring. The company says the "bio-artificial" pancreas can be used by type-1 diabetis patients and people with type-2 disease who require insulin injections.&nbsp;

Betalin Therapeutics aims to begin human testing early in 2021 and expects to launch it in the market in 2024, reports Guardian.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/world/1-in-10-hospitalised-covid-19-patients-with-diabetes-dies-study-301734">1 in 10 hospitalised Covid-19 patients with diabetes dies: Study</a>

The innovation is based on a biological scaffold, adapted from pig lung tissue. These hold beta cells which release insulin according to a patient's blood sugar levels.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/world/why-new-orleans-coronavirus-death-rate-is-leaping-diabetes-obesity-a-reason-290201">Why New Orleans coronavirus death rate is leaping? Diabetes, obesity a reason</a>

These artificial pancreas are very small and is implanted from the thigh using local anaesthesia.

"Our unique technology allows the body to heal itself,"&nbsp;said Nikolai Kunicher, the chief executive of the Israeli company said, adding that right now there focus is diabtetes but they intend to use this technology for other diseases too.&nbsp;

According to the International Diabetes Federation, over 460 million people around the world suffer from diabetes, however not all of them have been diagnosed.&nbsp;

A World Health Organization (WHO) study in 2016 said diabetes was the seventh most common cause of death, ahead of road injuries. 
&nbsp;

An Israeil firm that claims it has find a cure for diabetes has said it will send a request for initiation of human clinical trials next month in the UK. Betalin Therapeutics says it has created micro pancreas that will free diabetics from the need of insulin injections and blood sugar monitoring.

An Israeil firm that claims it has find a cure for diabetes has said it will send a request for initiation of human clinical trials next month in the UK. Betalin Therapeutics says it has created micro pancreas that will free diabetics from the need of insulin injections and blood sugar monitoring. The company says the "bio-artificial" pancreas can be used by type-1 diabetis patients and people with type-2 disease who require insulin injections. Betalin Therapeutics aims to begin human testing early in 2021 and expects to launch it in the market in 2024, reports Guardian. Also read | 1 in 10 hospitalised Covid-19 patients with diabetes dies: Study The innovation is based on a biological scaffold, adapted from pig lung tissue. These hold beta cells which release insulin according to a patient's blood sugar levels. Also read | Why New Orleans coronavirus death rate is leaping? Diabetes, obesity a reason These artificial pancreas are very small and is implanted from the thigh using local anaesthesia. "Our unique technology allows the body to heal itself," said Nikolai Kunicher, the chief executive of the Israeli company said, adding that right now there focus is diabtetes but they intend to use this technology for other diseases too. According to the International Diabetes Federation, over 460 million people around the world suffer from diabetes, however not all of them have been diagnosed. A World Health Organization (WHO) study in 2016 said diabetes was the seventh most common cause of death, ahead of road injuries.

Israeli firm says pancreas to cure diabetes ready for trials in UK

pancreas

Pancreas, News on Pancreas, stories on Pancreas, articles on Pancreas, Pancreas stories at Wion, Pancreas news, Pancreas latest news